TY - CHAP M1 - Book, Section TI - Network Meta-analysis A1 - Mills, Edward J. A1 - Ioannidis, John P. A. A1 - Thorlund, Kristian A1 - Schünemann, Holger J. A1 - Puhan, Milo A. A1 - Guyatt, Gordon A2 - Guyatt, Gordon A2 - Rennie, Drummond A2 - Meade, Maureen O. A2 - Cook, Deborah J. Y1 - 2015 N1 - T2 - Users' Guides to the Medical Literature: A Manual for Evidence-Based Clinical Practice, 3rd ed AB - CLINICAL SCENARIOYour patient is a 45-year-old woman who experiences frequent migraine headaches that last from 4 to 24 hours and prevent her from attending work or looking after her children. She has exhausted efforts to manage the symptoms with nonsteroidal anti-inflammatory drugs and seeks additional treatment. You decide to recommend a triptan for the patient's migraine headaches but are wondering how to choose from the 7 available triptans. You retrieve a network meta-analysis (NMA) that evaluates the different triptans among this patient population.1 You are not familiar with this type of study, and you wonder if there are special issues to which you should attend in evaluating its methods and results. SN - PB - McGraw-Hill Education CY - New York, NY Y2 - 2024/03/28 UR - jamaevidence.mhmedical.com/content.aspx?aid=1183877968 ER -